BC Innovations | Aug 23, 2012
Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Obesity; diabetes Peroxisomal reductase activating PPARg (PexRAP); peroxisome proliferation-activated receptor-g (PPARG; PPARg) Cell culture and mouse studies suggest inhibiting PexRAP could help treat diabetes...
Items per page:
1 - 1 of 1